NM_017668.3:c.872C>T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_017668.3(NDE1):​c.872C>T​(p.Ser291Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000515 in 1,614,226 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00055 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00051 ( 1 hom. )

Consequence

NDE1
NM_017668.3 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:4

Conservation

PhyloP100: 1.28

Publications

6 publications found
Variant links:
Genes affected
NDE1 (HGNC:17619): (nudE neurodevelopment protein 1) This gene encodes a member of the nuclear distribution E (NudE) family of proteins. The encoded protein is localized at the centrosome and interacts with other centrosome components as part of a multiprotein complex that regulates dynein function. This protein plays an essential role in microtubule organization, mitosis and neuronal migration. Mutations in this gene cause lissencephaly 4, a disorder characterized by lissencephaly, severe brain atrophy, microcephaly, and severe cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2012]
NDE1 Gene-Disease associations (from GenCC):
  • lissencephaly 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • hydranencephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • microlissencephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • NDE1-related microhydranencephaly
    Inheritance: Unknown, AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.019272298).
BP6
Variant 16-15696785-C-T is Benign according to our data. Variant chr16-15696785-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 159020.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000551 (84/152336) while in subpopulation AMR AF = 0.00164 (25/15290). AF 95% confidence interval is 0.00114. There are 0 homozygotes in GnomAd4. There are 31 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NDE1NM_017668.3 linkc.872C>T p.Ser291Phe missense_variant Exon 8 of 9 ENST00000396354.6 NP_060138.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NDE1ENST00000396354.6 linkc.872C>T p.Ser291Phe missense_variant Exon 8 of 9 1 NM_017668.3 ENSP00000379642.1

Frequencies

GnomAD3 genomes
AF:
0.000545
AC:
83
AN:
152218
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000647
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.000513
AC:
129
AN:
251306
AF XY:
0.000626
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000434
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000748
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000512
AC:
748
AN:
1461890
Hom.:
1
Cov.:
32
AF XY:
0.000527
AC XY:
383
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33480
American (AMR)
AF:
0.000470
AC:
21
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000869
AC:
75
AN:
86258
European-Finnish (FIN)
AF:
0.0000374
AC:
2
AN:
53416
Middle Eastern (MID)
AF:
0.00364
AC:
21
AN:
5768
European-Non Finnish (NFE)
AF:
0.000522
AC:
581
AN:
1112012
Other (OTH)
AF:
0.000679
AC:
41
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
50
99
149
198
248
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000551
AC:
84
AN:
152336
Hom.:
0
Cov.:
32
AF XY:
0.000416
AC XY:
31
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41596
American (AMR)
AF:
0.00164
AC:
25
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4832
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000661
AC:
45
AN:
68030
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0162
Hom.:
841
Bravo
AF:
0.000582
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000552
AC:
67
EpiCase
AF:
0.00115
EpiControl
AF:
0.000948

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Mar 19, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2019
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 29, 2024
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Oct 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Lissencephaly 4 Uncertain:2Benign:1
Feb 17, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Sep 01, 2017
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Likely pathogenicity based on finding it once in our laboratory in trans with a 16p13.11 deletion in a 1-year-old male with global delays, hypotonia, poor weight gain, optic atrophy, abnormal auditory brainstem responses, strabismus, brachycephaly. Heterozygotes are expected to be asymptomatic carriers. -

NDE1-related microhydranencephaly;C3151461:Lissencephaly 4 Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability Uncertain:1
Jan 01, 2019
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.12
T;T;T;T;T
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.34
FATHMM_MKL
Benign
0.44
N
LIST_S2
Uncertain
0.88
.;D;D;D;D
M_CAP
Benign
0.0075
T
MetaRNN
Benign
0.019
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.2
M;M;.;.;.
PhyloP100
1.3
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-1.4
N;N;.;.;.
REVEL
Benign
0.10
Sift
Uncertain
0.012
D;D;.;.;.
Sift4G
Uncertain
0.048
D;D;D;D;D
Polyphen
0.27
B;B;.;.;.
Vest4
0.55
MVP
0.69
MPC
0.096
ClinPred
0.035
T
GERP RS
3.6
Varity_R
0.076
gMVP
0.46
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146284370; hg19: chr16-15790642; COSMIC: COSV100707448; COSMIC: COSV100707448; API